A. Spreafico

Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck.

J. Waldron, B. O'Sullivan, A. Hope, 2020, Oral oncology.

HPV Status Improves Classification of Head and Neck Gray Zone Cancers

J. Waldron, R. Hung, B. Perez-Ordonez, 2019, Journal of dental research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.

Promising and Minimally Invasive Biomarkers: Targeting Melanoma

P. Spiliopoulou, Carlos Diego Holanda Lopes, A. Spreafico, 2023, Cells.

The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic Therapies

S. Saibil, D. Gray, A. Spreafico, 2023, Cancers.

Nodal Metastases in Stage 3 Head and Neck Melanoma: Patterns of Metastases and Patterns of Failure.

Sharon Tzelnick, Rajan Grewal, A. Spreafico, 2024, The Laryngoscope.

Tumor reactive γδ T cells contribute to a complete response to PD-1 blockade in a Merkel cell carcinoma patient

Derek L. Clouthier, Ramy Gadalla, Albiruni R. A. Razak, 2024, Nature communications.

Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study.

S. Bratman, I. Weinreb, Kyla Cochrane, 2024, British journal of cancer.